HHS medical innovation task force
Executive Summary
HHS task force on medical innovation is seeking comments on how the department can speed access of medical products to consumers, a notice published in the Federal Register May 24 states. Submissions will be accepted until Aug. 23, and a report is expected by year end. HHS Secretary Thompson announced the formation of the task force, which will be chaired by Acting Commissioner Lester Crawford, in April (1"The Pink Sheet" May 3, 2004, p. 19)...
You may also be interested in...
HHS Task Force Will Address Government Role In Speeding Drug Development
An HHS task force will examine ways the government can help accelerate the process of medical innovation, Secretary Thompson said April 26
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.